Exploiting synthetic lethal interactions for the treatment of human cancer
Exploiting synthetic lethal interactions for the treatment of human cancer. DNA damage signaling networks commonly show extensive rewiring incancercells.(A)Inp53andATM-proficient cancer cells primarily promotes apoptosis. Due to a functional proapoptotic ATM-Chk2-p53- Puma/Noxa signaling axis conventional DNA-damaging chemotherapeutics should be recommended. (B) Loss of p53 in cancer cells largely abrogates DNA damage-induced apoptosis. in these cells ATM signaling is re-directed to induce a robust cell cycle arrest following genotoxic stress. ATM-mediated homologous recombination repair remains intact in p53-deficient cancer cells. Rewiring of DNA damage-induced ATM signaling promotes cellular survival in response to DNA damage. Treatment of p53-deficient tumors should include a combination of conventional DNA-damaging chemotherapy and ATM inhibitors. (C) Loss of ATM selectively reduces the induction of the pro-apoptotic p53 target genes Puma and Noxa following genotoxic stress. induction of the cell cycle-regulatory p53 target genes p21 and Gadd45α remains intact allowing ATM-depleted cancer cells to arrest the cell cycle after DNA damage. ATM-deficient cancer cells with retained p53 expression depend on the DNA-PKcs-mediated NHEJ pathway to repair chemotherapy-induced DSBs and maintain genomic stability. Abolishing DNA-PKcs signaling in these cells results in a dramatically increased sensitivity to DNA-damaging chemotherapy. Treatment of ATM-deficient tumors with retained p53 expression should include a combination of conventional DNA-damaging chemotherapy and DNA-PKcs inhibitors. (D) The combined loss of ATM and p53 precludes the execution of functional cell cycle checkpoints in cancer cells that are exposed to DNA-damaging agents. This inability to halt progression through the cell cycle despite the presence of DNA damage ultimately results in mitotic catastrophe. p53 and ATM-deficient cancer cells should be exquisitely sensitive to treatment with conventional DNA-damaging chemotherapy.
Publication
Exploiting synthetic lethal interactions for targeted cancer therapy. () H. Christian Reinhardt, et al. Cell Cycle. ;8(19):3112-3119. Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Drosophila melanogaster | Invertebrates | p53 | P53 | ncbigene_symbol | p53 | 2768677 |
| Drosophila melanogaster | Invertebrates | p53 | P53 | ncbigene_synonym | betaTub60D | 37888 |
| Drosophila melanogaster | Invertebrates | p53 | P53 | ncbigene_synonym | hth | 41273 |
| Drosophila melanogaster | Invertebrates | ATM | ATM | ncbigene_synonym | tefu | 41839 |
| Drosophila melanogaster | Invertebrates | DSB | DSB | ncbigene_symbol | dsb | 38252 |
| Drosophila melanogaster | Invertebrates | ATRO | ATRO | ncbigene_synonym | Gug | 46156 |
| Drosophila melanogaster | Invertebrates | GIP | GIP | ncbigene_symbol | Gip | 31960 |
| Drosophila melanogaster | Invertebrates | (NHE | NHE | ncbigene_synonym | Nhe3 | 33939 |
| Drosophila melanogaster | Invertebrates | Cha | CHA | ncbigene_symbol | cha | 248106 |
| Drosophila melanogaster | Invertebrates | Cha | CHA | ncbigene_synonym | ChAT | 42249 |
| Drosophila melanogaster | Invertebrates | cycle | CYCLE | ncbigene_synonym | CycE | 34924 |
| Drosophila melanogaster | Invertebrates | cycle | CYCLE | ncbigene_synonym | cyc | 40162 |
| Drosophila melanogaster | Invertebrates | cych | CYCH | ncbigene_symbol | CycH | 40429 |
| Drosophila melanogaster | Invertebrates | ATR) | ATR | ncbigene_synonym | mei-41 | 32608 |
| Drosophila melanogaster | Invertebrates | ATR) | ATR | ncbigene_synonym | put | 41772 |
| Drosophila melanogaster | Invertebrates | ATR) | ATR | ncbigene_synonym | RYa-R | 43253 |
| Drosophila melanogaster | Invertebrates | PK | PK | ncbigene_symbol | pk | 45343 |
| Drosophila melanogaster | Invertebrates | Gadd45 | GADD45 | ncbigene_symbol | Gadd45 | 35646 |
| Drosophila melanogaster | Invertebrates | Fun | FUN | ncbigene_synonym | Sec8 | 40712 |
| Mus musculus | Rodents | p53 | P53 | ncbigene_synonym | Trp53 | 22059 |
| Mus musculus | Rodents | ATM | ATM | ncbigene_symbol | Atm | 11920 |
| Mus musculus | Rodents | ATM | ATM | ncbigene_synonym | Tpm1 | 22003 |
| Mus musculus | Rodents | CATM | CATM | ncbigene_synonym | Ctsm | 64139 |
| Mus musculus | Rodents | GIP | GIP | ncbigene_symbol | Gip | 14607 |
| Mus musculus | Rodents | GIP | GIP | ncbigene_synonym | Ctdsp1 | 227292 |
| Mus musculus | Rodents | Cha | CHA | ncbigene_synonym | Poc1a | 70235 |
| Mus musculus | Rodents | ATR) | ATR | ncbigene_symbol | Atr | 245000 |
| Mus musculus | Rodents | ATR) | ATR | ncbigene_synonym | Mmab | 77697 |
| Mus musculus | Rodents | PK | PK | ncbigene_symbol | pk | 18745 |
| Mus musculus | Rodents | DNAPK | DNAPK | ncbigene_synonym | Prkdc | 19090 |
| Mus musculus | Rodents | Gadd45 | GADD45 | ncbigene_synonym | Gadd45a | 13197 |
| Mus musculus | Rodents | Nua | NUA | ncbigene_synonym | Syne2 | 319565 |
| Mus musculus | Rodents | Puma | PUMA | ncbigene_synonym | Bbc3 | 170770 |
| Mus musculus | Rodents | Noxa | NOXA | ncbigene_synonym | Pmaip1 | 58801 |
| Homo sapiens | Primates | p53 | P53 | ncbigene_synonym | TP53 | 7157 |
| Homo sapiens | Primates | p53 | P53 | famplex_relations | TP63 | 8626 |
| Homo sapiens | Primates | p53 | P53 | famplex_relations | TP73 | 7161 |
| Homo sapiens | Primates | ATM | ATM | ncbigene_symbol | ATM | 472 |
| Homo sapiens | Primates | CATM | CATM | ncbigene_synonym | MCOPCT1 | 8130 |
| Homo sapiens | Primates | GIP | GIP | ncbigene_symbol | GIP | 2695 |
| Homo sapiens | Primates | GIP | GIP | ncbigene_synonym | GNAI2 | 2771 |
| Homo sapiens | Primates | GIP | GIP | ncbigene_synonym | C1QTNF1 | 114897 |
| Homo sapiens | Primates | (NHE | NHE | ncbigene_synonym | SLC9C1 | 285335 |
| Homo sapiens | Primates | Cha | CHA | ncbigene_synonym | TCFL5 | 10732 |
| Homo sapiens | Primates | cych | CYCH | ncbigene_synonym | CCNH | 902 |
| Homo sapiens | Primates | ATR) | ATR | ncbigene_symbol | ATR | 545 |
| Homo sapiens | Primates | ATR) | ATR | ncbigene_synonym | ANTXR1 | 84168 |
| Homo sapiens | Primates | ATR) | ATR | ncbigene_synonym | MMAB | 326625 |
| Homo sapiens | Primates | ATR) | ATR | ncbigene_synonym | SERPINA2 | 390502 |
| Homo sapiens | Primates | DNAPK | DNAPK | ncbigene_synonym | PRKDC | 5591 |
| Homo sapiens | Primates | Gadd45 | GADD45 | ncbigene_synonym | GADD45A | 1647 |
| Homo sapiens | Primates | Nua | NUA | ncbigene_synonym | SYNE2 | 23224 |
| Homo sapiens | Primates | Puma | PUMA | ncbigene_synonym | BBC3 | 27113 |
| Homo sapiens | Primates | Noxa | NOXA | ncbigene_synonym | PMAIP1 | 5366 |
| Danio rerio | Vertebrates | p53 | P53 | ncbigene_synonym | tp53 | 30590 |
| Danio rerio | Vertebrates | ATM | ATM | ncbigene_symbol | atm | 403064 |
| Danio rerio | Vertebrates | GIP | GIP | ncbigene_symbol | gip | 790901 |
| Danio rerio | Vertebrates | Cha | CHA | ncbigene_synonym | dand5 | 791454 |
| Danio rerio | Vertebrates | ATR) | ATR | ncbigene_symbol | atr | 567770 |
| Arabidopsis thaliana | Plants and Fungi | ATM | ATM | ncbigene_symbol | ATM | 823975 |
| Arabidopsis thaliana | Plants and Fungi | Cha2 | CHA2 | ncbigene_synonym | BRM | 819210 |
| Arabidopsis thaliana | Plants and Fungi | ATR) | ATR | ncbigene_symbol | ATR | 834082 |
| Arabidopsis thaliana | Plants and Fungi | Nua | NUA | ncbigene_symbol | NUA | 844268 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|